| Name | Organization | Research Summary | |
|---|
| Chen, Zibo | Westlake University | The Chen Lab combines mammalian synthetic biology with de novo protein design to write biological programs at the molecular, cellular, and tissue levels. | ViewMap |
| Charpentier, Emmanuelle | Max Planck Institute for Science of Pathogens | Needs update | ViewMap |
| Cao, Longxing | Westlake University | developing new de novo protein design methods and apply these methods for cutting-edge therapeutics | ViewMap |
| Bystroff, Christopher | Rensselaer Polytechnic Institute | Vaccine design, biosensor design | ViewMap |
| Brunette, TJ | Align Bio | My research focuses on developing protein design methods for generating large datasets and designing experiments that utilize cloud-based labs. | ViewMap |
| Brown, Benjamin | Vanderbilt University | We combine precision medicine computational structural biology with computer-aided small molecule drug discovery. | ViewMap |
| Bradley, Philip | Fred Hutchinson Cancer Research Center | Protein fold design and protein interaction specificity, especially in the immune system | ViewMap |
| Boyden, Ed | Massachusetts Institute of Technology | Protein engineering | ViewMap |
| Bonneau, Rich | New York University | Needs update | ViewMap |
| Bjelic, Sinisa | Linnaeus University | Intersted in functionalizing proteins, understanding biology, and having fun! | ViewMap |
| Bhardwaj, Gaurav | University of Washington | Computational peptide design for targeted therapeutics | ViewMap |
| Barth, Patrick | Ecole Polytechnique Federale de Lausanne (EPFL) | we develop and apply computational/experimental approaches for designing proteins and cells with novel functionalities | ViewMap |
| Baker, David | University of Washington | We develop protein design software and use it to create molecules that solve modern challenges in medicine, technology and sustainability. | ViewMap |
| Bahl, Christopher | Harvard University | de novo design of miniprotein therapeutics | ViewMap |
| Azoitei, Mihai | Duke University | Research in our group is focused on two synergistic areas that are critical for the development of vaccines against highly infectious pathogens: 1) rational immunogen design; and 2) determining the immunogen properties that lead to B cell activation. | ViewMap |
| André, Ingemar | Lund University | Design of protein assembly formation and conformational change | ViewMap |
| Ambroggio, Xavier | Rosetta Design Group | Macromolecular modeling for the advancement and understanding of human health and disease. | ViewMap |
